Martin Schlun

PARI was founded in Wuppertal in 1906 and has progressed during its more than 100 years of company history from a small manufacturer to a globally respected specialist in respiratory therapy. At present, the PARI business group is headquartered in Starnberg, Germany with additional locations in Weilheim, Germany (PARItec, production) and Gräfelfing, Germany (PARI Pharma, medicinal products and eFlow technology). In addition, there are international branch offices and a worldwide distribution network. As a manufacturer of medical devices with a focus on respiratory therapy, PARI has been the brand to trust for doctors, pharmacists and patients, for many decades. Continuous development and steady growth enabled PARI to expand their market leadership in Germany for equipment, saline solutions and respiratory aids. PARI is the global market leader in the field of nebuliser devices for cystic fibrosis. PARI offers specially optimized devices and solutions for inhalation for pulmonary, bronchial and also nasopharyngeal diseases. A broad portfolio is used to provide patients with comprehensive care, ranging from diagnosis and treatment to monitoring. PARI’s mission is to improve the lives of those affected by respiratory diseases and those who provide care to them. In addition to innovative products and tailored solutions, PARI also offers comprehensive services for users, medical professionals and distribution partners. Are you seeking new career opportunities? Visit our website www.pari.com and find out more about open positions.